ETF Managers Group, LLC Athersys, Inc Transaction History

ETF Managers Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.18 - $0.86 $1,805 - $8,627	10,032 Added 14.06%	81,386 $23,000
Q1 2022 May 13, 2022	BUY	$0.6 - $1.06 $138 - $243	230 Added 0.32%	71,354 $43,000
Q4 2021 Feb 14, 2022	SELL	$0.85 - $1.4 $6,195 - $10,204	-7,289 Reduced 9.3%	71,124 $62,000
Q3 2021 Nov 15, 2021	BUY	$1.33 - $1.77 $17,109 - $22,769	12,864 Added 19.63%	78,413 $107,000
Q2 2021 Aug 16, 2021	BUY	$1.41 - $1.94 $7,037 - $9,682	4,991 Added 8.24%	65,549 $92,000
Q1 2021 May 17, 2021	SELL	$1.61 - $2.77 $57,319 - $98,617	-35,602 Reduced 37.02%	60,558 $99,000
Q4 2020 Feb 16, 2021	SELL	$1.55 - $2.24 $22,389 - $32,356	-14,445 Reduced 13.06%	96,160 $178,000
Q3 2020 Nov 16, 2020	BUY	$1.91 - $3.08 $104,849 - $169,076	54,895 Added 98.54%	110,605 $225,000
Q2 2020 Aug 14, 2020	BUY	$1.97 - $3.98 $109,748 - $221,725	55,710 New	55,710 $153,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.